Terms: = Prostate cancer AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK
1238 results:
1. Knockdown of growth differentiation factor-15 restrains prostate cancer through regulating MAPK/erk signaling pathway.
Yang M; Guo M; Su C; Hao W; Xu Z
Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):162-167. PubMed ID: 38650142
[TBL] [Abstract] [Full Text] [Related]
2. IQGAP1 and NWASP promote human cancer cell dissemination and metastasis by regulating β1-integrin via FAK and MRTF/SRF.
Cerutti C; Lucotti S; Menendez ST; Reymond N; Garg R; Romero IA; Muschel R; Ridley AJ
Cell Rep; 2024 Apr; 43(4):113989. PubMed ID: 38536816
[TBL] [Abstract] [Full Text] [Related]
3. Tyrosine phosphatase
Chen X; Keller SJ; Hafner P; Alrawashdeh AY; Avery TY; Norona J; Zhou J; Ruess DA
Front Immunol; 2024; 15():1340726. PubMed ID: 38504984
[TBL] [Abstract] [Full Text] [Related]
4. A plasma membrane-associated form of the androgen receptor enhances nuclear androgen signaling in osteoblasts and prostate cancer cells.
Kalyanaraman H; Casteel DE; China SP; Zhuang S; Boss GR; Pilz RB
Sci Signal; 2024 Jan; 17(821):eadi7861. PubMed ID: 38289986
[TBL] [Abstract] [Full Text] [Related]
5. Leptin promotes proliferation of human undifferentiated spermatogonia by activating the PI3K/AKT/mTOR pathway.
Xin S; Xiaoxuan L; Yixuan Z; Zhikang C
Am J Reprod Immunol; 2024 Jan; 91(1):e13811. PubMed ID: 38282611
[TBL] [Abstract] [Full Text] [Related]
6. Sinularin stabilizes FOXO3 protein to trigger prostate cancer cell intrinsic apoptosis.
Meng XY; Wang KJ; Ye SZ; Chen JF; Chen ZY; Zhang ZY; Yin WQ; Jia XL; Li Y; Yu R; Ma Q
Biochem Pharmacol; 2024 Feb; 220():116011. PubMed ID: 38154548
[TBL] [Abstract] [Full Text] [Related]
7. Antitumor Activity and Mechanism of Terpenoids in Seaweeds Based on Literature Review and Network Pharmacology.
Chen B; Li Y; Li W; Ye S; Zhu L; Ding Y
Adv Biol (Weinh); 2024 Mar; 8(3):e2300541. PubMed ID: 38134388
[TBL] [Abstract] [Full Text] [Related]
8. ADORA2A-driven proline synthesis triggers epigenetic reprogramming in neuroendocrine prostate and lung cancers.
Jing N; Zhang K; Chen X; Liu K; Wang J; Xiao L; Zhang W; Ma P; Xu P; Cheng C; Wang D; Zhao H; He Y; Ji Z; Xin Z; Sun Y; Zhang Y; Bao W; Gong Y; Fan L; Ji Y; Zhuang G; Wang Q; Dong B; Zhang P; Xue W; Gao WQ; Zhu HH
J Clin Invest; 2023 Dec; 133(24):. PubMed ID: 38099497
[TBL] [Abstract] [Full Text] [Related]
9. JNK promotes the progression of castration-resistant prostate cancer.
Feng Y; Cao H; Wang D; Chen L; Gao R; Sun P
Acta Biochim Pol; 2023 Dec; 70(4):817-822. PubMed ID: 38099475
[TBL] [Abstract] [Full Text] [Related]
10. Ursolic Acid's Alluring Journey: One Triterpenoid vs. cancer Hallmarks.
Limami Y; Pinon A; Wahnou H; Oudghiri M; Liagre B; Simon A; Duval RE
Molecules; 2023 Dec; 28(23):. PubMed ID: 38067626
[TBL] [Abstract] [Full Text] [Related]
11.
Giordano F; Comità S; Venneri G; Rago V; Naimo GD; De Amicis F; De Bartolo A; Tundis R; Mauro L; Panno ML
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003541
[TBL] [Abstract] [Full Text] [Related]
12. Suppression of TNBC metastasis by doxazosin, a novel dual inhibitor of c-MET/EGFR.
Kim S; Park JM; Park S; Jung E; Ko D; Park M; Seo J; Nam KD; Kang YK; Lee K; Farrand L; Kim YJ; Kim JY; Seo JH
J Exp Clin Cancer Res; 2023 Nov; 42(1):292. PubMed ID: 37924112
[TBL] [Abstract] [Full Text] [Related]
13. Total flavonoids of Litchi chinensis Sonn. seed inhibit prostate cancer growth in bone by regulating the bone microenvironment via inactivation of the HGFR/NF-κB signaling pathway.
Zhang W; Chen T; Yang P; Li X; Zhu D; Su Z; Yang X; Jin R; Lan T; Guo H
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117327. PubMed ID: 37871755
[TBL] [Abstract] [Full Text] [Related]
14. prostate cancer Stem Cells: Biology and Treatment Implications.
Koukourakis IM; Platoni K; Kouloulias V; Arelaki S; Zygogianni A
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834336
[TBL] [Abstract] [Full Text] [Related]
15. Polyphyllin I induces ferroptosis in castration-resistant prostate cancer cells through the erk/DNMT1/ACSL4 axis.
Zou P; Chen Z; He Q; Zhuo Y
Prostate; 2024 Jan; 84(1):64-73. PubMed ID: 37750290
[TBL] [Abstract] [Full Text] [Related]
16. A novel isoxazole compound CM2-II-173 inhibits the invasive phenotype of triple-negative breast cancer cells.
Kim ES; Kim S; Moon A
Oncol Res; 2023; 31(6):867-875. PubMed ID: 37744269
[TBL] [Abstract] [Full Text] [Related]
17. RNA Interference against ATP as a Gene Therapy Approach for prostate cancer.
Chen S; Ma J; Xiao Y; Zhou D; He P; Chen Y; Zheng X; Lin H; Qiu F; Yuan Y; Zhong J; Li X; Pan X; Fang Z; Wang C
Mol Pharm; 2023 Oct; 20(10):5214-5225. PubMed ID: 37733628
[TBL] [Abstract] [Full Text] [Related]
18. Resistin stimulates PC-3 prostate cancer cell growth through stimulation of SOCS3 and SOCS5 genes.
Liu CW; Peng HY; Siao AC; Tsuei YW; Lin YY; Shiah SG; Shih LJ; Yeh CC; Lee SW; Kao YH
Exp Biol Med (Maywood); 2023 Oct; 248(20):1695-1707. PubMed ID: 37646261
[TBL] [Abstract] [Full Text] [Related]
19. Protein kinase D activity is a risk biomarker in prostate cancer that drives cell invasion by a Snail/erk dependent mechanism.
Cilleros-Rodríguez D; Toledo-Lobo MV; Martínez-Martínez D; Baquero P; Angulo JC; Chiloeches A; Iglesias T; Lasa M
Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166851. PubMed ID: 37611675
[TBL] [Abstract] [Full Text] [Related]
20. ASCL1 is activated downstream of the ROR2/CREB signaling pathway to support lineage plasticity in prostate cancer.
Tabrizian N; Nouruzi S; Cui CJ; Kobelev M; Namekawa T; Lodhia I; Talal A; Sivak O; Ganguli D; Zoubeidi A
Cell Rep; 2023 Aug; 42(8):112937. PubMed ID: 37552603
[TBL] [Abstract] [Full Text] [Related]
[Next]
